Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

St3gal1 and bII-spectrin pathways control CAR-T cell migration to target tumor sites [1]

ABSTRACT: St3gal1 and bII-spectrin pathways control CAR-T cell migration to target tumor sites [1]

PROVIDER: PRJNA945035 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23870670.fastq.gz	Fastqsanger.gz
	SRR23870671.fastq.gz	Fastqsanger.gz
	SRR23870672.fastq.gz	Fastqsanger.gz
	SRR23870673.fastq.gz	Fastqsanger.gz
	SRR23870674.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 9

Similar Datasets

St3gal1 and bII-spectrin pathways control CAR-T cell migration to target tumor sites [3]

Project description:Adoptive transfer of genetically engineered chimeric antigen receptor (CAR)-T cell is emerging as a promising treatment option for hematological malignancies. However, T cell immunotherapies have largely failed in patients with solid tumors. Here, with a CRISPR-Cas9 pooled library, we performed an in vivo targeted loss-of-function screen and identified ST3 b-galactoside a-2,3-sialyltransferase 1 (St3gal1) as a key negative regulator of the cancer-specific migration of CAR-T cells. Analysis of glycosylated proteins reveals that CD18 is a major effector of St3gal1 in activated CD8 T cells. St3gal1-mediated glycosylation induces the spontaneous nonspecific tissue sequestration of T cells by altering lymphocyte function-associated antigen-1 (LFA-1) endocytic recycling. Engineered CAR-T cells with enhanced expression of bII-spectrin, a key LFA-1 associated cytoskeleton molecule, reversed St3gal1-mediated nonspecific T cell migration and significantly reduced tumor growth in mice by improving tumor-specific homing of CAR-T cells. These findings identify a role of the St3gal1- bII-spectrin axis as the key cell-intrinsic program for cancer targeting CAR-T cell migration and as a promising strategy for effective T cell immunotherapy.

2023-03-17 | GSE227509 | GEO

St3gal1 and bII-spectrin pathways control CAR-T cell migration to target tumor sites [2]

2023-03-17 | GSE227430 | GEO

St3gal1 and bII-spectrin pathways control CAR-T cell migration to target tumor sites [1]

2023-03-17 | GSE227429 | GEO

St3gal1 and bII-spectrin pathways control CAR-T cell migration to target tumor sites

Project description:St3gal1 and bII-spectrin pathways control CAR-T cell migration to target tumor sites

| PRJNA945033 | ENA

St3gal1 and bII-spectrin pathways control CAR-T cell migration to target tumor sites [3]

Project description:St3gal1 and bII-spectrin pathways control CAR-T cell migration to target tumor sites [3]

| PRJNA945418 | ENA

St3gal1 and bII-spectrin pathways control CAR-T cell migration to target tumor sites [2]

Project description:St3gal1 and bII-spectrin pathways control CAR-T cell migration to target tumor sites [2]

| PRJNA945036 | ENA

St3gal1 and bII-spectrin pathways control CAR-T cell migration to target tumor sites

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-03-17 | GSE227431 | GEO

CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS

Project description:The major Coxsackie-Adenovirus receptor, CAR, is specifically down-regulated in immature erythroid progenitor cells in patients with MDS CAR mediates erythroid maturation in progenitor cells and their migration which may explain the maturation defect and pathology in MDS

2021-12-01 | GSE147963 | GEO

Stenotrophomonas bentonitica BII-R7proteome in presence of Se(IV)

Project description:Tandem mass spectrometry analysis of Stenotrophomonas bentonitica BII-R7 cells grown in absence or presence of 2 mM sodium selenite and sampled at three different time-points.

2022-04-23 | PXD023459 | Pride

TRX1-enhanced CAR T cells retain their antitumor functions under pro-oxidative conditions

Project description:Immunotherapies with CAR-T cells achieve remarkable success, especially against B-cell malignancies. However, their activity against non-hematopoietic solid tumors is very limited. One central cause of this failure may be that a pro-oxidative tumor microenvironment can downmodulate the activation and migration of T-cells. In contrast to tumor cells, primary T cells have very low levels of antioxidants. This makes them prone to pro-oxidative effects. Oxidation-induced dysregulation of actin cytoskeletal dynamics hinders T-cell migration which allows only low tumor infiltration rates. In addition, the proliferation and the effector functions of T-cells (tumor cell killing) are disrupted. In order to strengthen human CAR-T cells against a pro-oxidative tumor microenvironment, we have increased increase their antioxidant capacity, e.g. by expressing antioxidants. We aimed to characterize the importance of antioxidant empowerment at functional level and at the molecular level. Among the antioxidant systems, thioredoxin1 (TRX1)-empowerment, allowed CAR T cells to retain their capacities for cytolytic immune synapse formation, cytokine release, proliferation, and cytotoxicity under pro-oxidative conditions. At the molecular level, gene expression analysis revealed that a pro-oxidative micromilieu caused a downmodulation of costimulatory and cytokine signals of T cells. One unique focus of this study was also to investigate global influence of reactive oxygen species on protein oxidation in T cells. Therefore, using TRX1 kinetic trapping and consequently mass spectrometry was employed to get insight into global oxidation levels in T cells. This analysis, namely redoxosome analysis, unveiled 196 oxidized proteins which were annotated to regulate several antitumor T cell functions. Taken together, our results provide evidence that TRX1 empowerment can increase CAR T cell efficacy against solid tumors.

2022-11-23 | PXD031073 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data